ECElizabeth Critchlow

Elizabeth Critchlow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elizabeth Critchlow has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Provider Practice and Patient Clinical Follow‐Up Among Patients With Spinal Muscular Atrophy (SMA) Linked‐Variant

    by Elizabeth Critchlow, Whitney Bender, Melissa Riegel, Lorraine Dugoff

    Background: The American College of Obstetricians and Gynecologists (ACOG) recommends spinal muscular atrophy (SMA) carrier screening be offered preconception or prenatally. SMA linked‐variant incurs an increased but not absolute risk of being a carrier. Objective: To describe the patient population, clinical recommendations, and follow‐up in a cohort with SMA linked‐variant. Study Design: This is a retrospective cohort study performed at an urban, academic, tertiary care center of patients with the SMA linked‐variant approximately 2017–2021. Descriptive statistics characterize the patient population, provider recommendations, and patient follow‐up. Results: There were 856 patients, majority Black (94.2%), who tested positive for the SMA linked‐variant. There was documentation of result disclosure to patients in only 62.6% of cases. Genetic counseling (88.8%) and partner testing (62.5%) were most often offered. At least one suggested follow‐up was completed by 29.1% of patients, with 162 patients (30.2%) receiving genetic counseling and 61 (11.4%) undergoing partner testing. Conclusion: Providers documented disclosure of SMA linked‐variant results in only 2/3 of cases, and patients completed at least some of the offered clinical follow‐up in only 1/3 of cases, both major gaps in care quality. Additional research is needed to understand and improve the suboptimal result review and low rates of patient follow‐up.

  • Open Access

    High Diagnosis Rate for Nonimmune Hydrops Fetalis With Prenatal Clinical Genome: Expanded Results From the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing ( HYDROPS ) Study

    by Stephanie M. Rice, Mona M. Makhamreh, Sascha Wodoslawsky, Mariella Toro, Elizabeth Critchlow, Brandy Firman, Ruby Liu, Babi Ramesh Nallamilli, Madhuri Hegde, Seth I. Berger, et al.

    Nonimmune hydrops fetalis (NIHF) is characterized by abnormal fluid accumulation in ≥ 2 fetal compartments and may be genetic. The incremental diagnostic yield of prenatal exome sequencing (ES) for NIHF following a negative standard workup was previously explored on 22 cases. We report ES findings in the remaining cohort and investigate the incremental yield of genome sequencing (GS) in cases without a definitive diagnosis from exome. Enrollment criteria and exome methodology for the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) study were previously reported. Exomes without a definitive diagnosis were reviewed with updated clinical information and had GS if DNA was available. A genetic counselor returned the clinical reports. Overall, 50 exomes yielded 22 (44%) diagnoses and six possible diagnoses (12%). Nine new cases (9/28, 68%) had a diagnosis involving one of the following genes: RIT1, SOS1, RYR1, FLT4, LMOD2, KMT2D, PUF60, and BLTP1 . Two additional cases were diagnosed upon reclassification of uncertain variants. GS of eligible ES cases resulted in an incremental diagnostic yield of 7% (1/14). ES and GS in NIHF significantly reduce the number of unexplained cases and guide clinical management and recurrence risks. Currently, the incremental diagnostic yield of GS over ES in NIHF remains under investigation. Trial Registration: ClinicalTrials.gov identifier: NCT03911531

  • Open Access

    Spinal Muscular Atrophy Carrier Screening: Assessment of Provider Knowledge and Clinical Practice

    by Melissa Riegel, Whitney Bender, Elizabeth Critchlow, Lorraine Dugoff

    Objective: The American College of Obstetricians and Gynecologists (ACOG) recommends offering spinal muscular atrophy (SMA) carrier screening (CS) preconception or prenatally. This study aimed to determine provider knowledge of SMA and SMA CS practice patterns and to describe the relationship between knowledge and comfort while discussing screening and results. Method: Prenatal providers completed an anonymous web‐based survey on SMA knowledge, CS practice patterns, and comfort in interpretation of results. Data were summarized with descriptive statistics. The relationship between provider training and SMA knowledge with provider comfort was analyzed. Results: 75% (112/150) of providers responded and 64.6% completed the survey. Participants varied in roles and years of experience. The mean score on knowledge was 3.8/8 (47.5%) with 20.6% of respondents scoring ≥ 75% and 51.6% scoring ≥ 50%. Knowledge did not vary with years of experience. Although 91.3% of providers offer SMA screening, less than 25% reported complete comfort discussing screening and results. Comfort correlated with role and experience. Providers who felt completely comfortable discussing SMA screening had higher knowledge scores. Conclusion: Although the majority of providers offer SMA CS, provider knowledge regarding SMA is low, and most are not comfortable discussing screening and results.


  • Open Access

    Unnecessary Antibiotics in Older Female Patients with Recurrent Urinary Tract Infections

    by Elizabeth Critchlow, Alexandra Kuzma, Nathanael Koelper, Surbhi Agrawal, Lauren Dutcher, Lily Arya

    Introduction: Our aim was to describe the rate of unnecessary antibiotic prescriptions across specialties and the frequency of clinical scenarios in which the unnecessary antibiotics were prescribed in older female patients with recurrent urinary tract infections (UTI). Methods: This was a retrospective cohort study of female patients 65 or older with a clinical diagnosis of recurrent UTI. An unnecessary antibiotic was defined as an antibiotic prescribed (i) for asymptomatic bacteriuria (positive culture in the absence of UTI-specific symptoms), (ii) in the absence of UTI-specific symptoms, or (iii) in the presence of documented negative urine culture or negative pyuria. Data on clinical scenarios during episodes when an unnecessary antibiotic was prescribed (such as symptom documentation, urine testing) were extracted and described. Results: The overall rate of unnecessary antibiotics across 454 episodes of antibiotic prescriptions in 175 older female patients with recurrent UTI was 41% and did not significantly differ between specialties (primary care 45%, urogynecology 41%, obstetrics-gynecology 29%, urology 28%, urgent care 27%, p = 0.06). The commonest clinical scenario during which an unnecessary antibiotic was prescribed was absence of documented UTI-specific symptoms (60%) followed by asymptomatic bacteriuria (46%). Other clinical scenarios associated with unnecessary antibiotics included antibiotics prescribed with documented negative pyuria (32%) or negative urine culture (18%). In 11% of episodes, antibiotics were prescribed without any documented UTI-specific symptom and without any testing. Conclusion: Inadequate symptom documentation and inappropriate urine testing contribute to a high rate of unnecessary antibiotic prescribing in older female patients with recurrent UTI. Clinical decision support tools that address these gaps could promote antibiotic stewardship.


  • Open Access

    Prenatal Phenotype of Alkuraya‐Kučinskas Syndrome: A Novel Case and Systematic Literature Review

    by Stephanie M. Rice, Dante F. Varotsis, Sascha Wodoslawsky, Elizabeth Critchlow, Ruby Liu, Rodney A. McLaren, Mona M. Makhamreh, Brandy Firman, Seth I. Berger, Huda B. Al‐Kouatly

    Alkuraya‐Kučinskas syndrome (AKS) is an autosomal recessive multisystem disorder resulting from mutations in the BLTP1 gene, formerly known as KIAA1109. Primary manifestations include brain malformations, arthrogryposis, and clubfeet. Cardiac, renal, and ophthalmologic abnormalities may also be observed, while nonimmune hydrops is rare. We present a case of two novel BLTP1 canonical splice‐site variants in a fetus with multiple congenital anomalies, including hydrops, a kinked brainstem, and joint contractures. A systematic literature review was conducted to describe the prenatal phenotype of AKS, which was inspired by our case. Our systematic literature review of the prenatal phenotype in 19 cases, including our additional case, demonstrated joint contractures in 90% (18/20), ventriculomegaly in 60% (12/20), brainstem dysgenesis in 50% (10/20), cerebellar hypoplasia in 50% (10/20), parenchymal thinning with lissencephalic aspect in 60% (12/20), and facial dysmorphism in 70% (14/20) of reported AKS cases. In addition to our case, hydrops was reported in two other families. AKS should be considered in fetal presentations with characteristic features, especially brainstem kinking and joint contractures. Exome sequencing, including coverage of canonical intronic splice‐site variants, can clarify the diagnosis.Trial Registration: ClinicalTrials.gov registration: NCT03911531


  • RASopathies are the most common set of monogenic syndromes identified by exome sequencing for nonimmune hydrops fetalis: A systematic review and meta‐analysis

    by Mona M. Makhamreh, Kavya Shivashankar, Sarah Araji, Elizabeth Critchlow, Barbara M. O'BRien, Sascha Wodoslawsky, Seth I. Berger, Huda B. Al‐Kouatly

    RASopathies are a group of malformation syndromes known to lead to nonimmune hydrops fetalis (NIHF) in severe presentations. Pathogenic variants can be de novo or parentally inherited. Despite being a known frequent presentation, the fraction of monogenic NIHF cases due to RASopathies is limited in the literature. Also, the specific parental contribution of RASopathies to NIHF is not well described. Our objective was to review pooled exome sequencing (ES) diagnostic yield of RASopathies for NIHF and to determine the parental contribution of RASopathy to NIHF. We performed a systematic review of prenatal ES studies from January 1, 2000 to August 1, 2022. Thirty‐six studies met inclusion criteria. Cases with RASopathy gene variants were reviewed. NIHF cases were further classified as isolated or non‐isolated. Thirty‐six ES studies including 46 pregnancies with NIHF and a diagnosed RASopathy were reviewed. Forty‐four diagnostic variants and 2 variants of uncertain significance in 12 RASopathy genes were identified. Expanding on what was previously published, a total of 506 NIHF cases were extracted with 191 cases yielding a positive diagnosis by ES. The overall rate of RASopathy diagnosis in clinically diagnosed NIHF cases was 9% (44/506). The rate of RASopathy diagnosis among NIHF cases with positive genetic diagnosis by ES was 23% (44/191). Of the 46 cases identified, 13 (28%) variants were parentally inherited; specifically, 5/13 (38%) maternal, 3/13 (23%) paternal, 2/13 (15%) biparental, and 3/13 (23%) unspecified. Majority of NIHF cases 29/46 (63%) were isolated. Among NIHF cases with positive ES diagnoses, RASopathy diagnostic yield by ES was 23%. NIHF secondary to RASopathies was parentally inherited in 28% of cases. Most cases of NIHF due to RASopathy were isolated, with no prenatal detection of associated anomalies.


  • Maternal outcomes of a cohort of pregnancies affected by non‐immune hydrops fetalis

    by Elizabeth Critchlow, Sascha Wodoslawsky, Mona M. Makhamreh, Stephanie M. Rice, Ozhan M. Turan, Brandy Firman, Rodney McLaren, Sara Araji, Huda B. Al‐Kouatly

    Objective: To describe the maternal outcomes of a prospective cohort of non‐immune hydrops fetalis (NIHF) pregnancies with negative standard‐of‐care evaluations.Methods: This study was a secondary analysis of a prospective cohort study of NIHF pregnancies with negative work‐ups (infection, alloimmune anemia, fetomaternal hemorrhage, and chromosomal disorders). Outcomes were obstetric complications, including pre‐eclampsia, mirror syndrome, preterm birth, polyhydramnios, postpartum hemorrhage, and maternal mental health.Results: Forty pregnancies were included. Four patients developed pre‐eclampsia (4/40, 10.0%); three occurred postpartum. None was diagnosed with mirror syndrome. Of the 31 continued pregnancies, 16 (51.6%) resulted in early fetal death or stillbirth and 15 (48.4%) resulted in live births. Of the 15 live births, 8 (53.3%) were delivered by primary cesarean delivery; 5 (62.5%) were for hydrops fetalis. Eleven live births (73.3%) were delivered preterm; 9 (81.8%) were indicated, most commonly for fetal indications (7/9, 77.8%). Polyhydramnios occurred in 14/40 (35.0%) cases. Where EBL was recorded (n=37), there were 5 (13.5%) cases of postpartum hemorrhage and an additional 3 (8.1%) had uterine atony without hemorrhage. Eighteen patients (18/40, 45.0%) had new‐onset or exacerbated depression or anxiety symptoms.Conclusion: Our study identified several important adverse outcomes of pregnancies complicated by NIHF with negative standard‐of‐care evaluations, including a high rate of postpartum pre‐eclampsia and worsened mental health. We identified a higher rate of cesarean delivery and preterm birth, both primarily for fetal indications. We also observed the known relationship between polyhydramnios, hemorrhage, and atony, but noted that this risk included pregnancies concluding in dilation and evacuation. Counseling after a diagnosis of NIHF should include these adverse outcomes.


  • Diagnostic yield from prenatal exome sequencing for non‐immune hydrops fetalis: A systematic review and meta‐analysis

    by Huda B. Al‐Kouatly, Kavya Shivashankar, Matthew H. Mossayebi, Mona Makhamreh, Elizabeth Critchlow, Zimeng Gao, Luther‐King Fasehun, Fowzan S. Alkuraya, Erin E. Ryan, Madhuri Hegde, et al.

    Non‐immune hydrops fetalis (NIHF) has multiple genetic etiologies diagnosable by exome sequencing (ES). We evaluated the yield of prenatal ES for NIHF, and the contribution of additional clinical findings and history. Systematic review was performed with PROSPERO tag 232951 using CINAHL, PubMed, and Ovid MEDLINE from January 1, 2000 through December 1, 2021. Selected studies performed ES to augment standard prenatal diagnostic approaches. Cases meeting a strict NIHF phenotype were tabulated with structured data imputed from papers or requested from authors. Genetic variants and diagnostic outcomes were harmonized across studies using current ACMG and ClinGen variant classification guidelines. Thirty‐one studies reporting 445 NIHF cases had a 37% (95% CI: 32%–41%) diagnostic rate. There was no significant difference between isolated NIHF and NIHF with fetal malformations or between recurrent and simplex cases. Diagnostic rate was higher for consanguineous than non‐consanguineous cases. Disease categories included RASopathies (24%), neuromuscular (21%), metabolic (17%), lymphatic (13%), other syndromes (9%), cardiovascular (5%), hematologic (2%), skeletal (2%), and other categories (7%). Inheritance patterns included recessive (55%), dominant (41%), and X‐linked (4%). ES should be considered in the diagnostic workup of NIHF with and without associated ultrasound findings regardless of history of recurrence or consanguinity.


  • Placental phenotype in non‐immune hydrops fetalis with negative standard workup

    by R. Horgan, E. Critchlow, S. Wodoslawsky, S. Rice, J. L. Hecht, H. B. Al‐Kouatly


  • Experiences of New Mothers During the Coronavirus Disease 2019 (COVID-19) Pandemic

    by Elizabeth Critchlow, Lyena Birkenstock, Melanie Hotz, Lauren Sablone, Amy Henderson Riley, Rebecca Mercier, Rosemary Frasso

    OBJECTIVE: To describe postpartum experiences of women who gave birth during the coronavirus disease 2019 (COVID-19) pandemic, to identify short-term and long-term opportunities to address maternal–child health during this pandemic. METHODS: This qualitative photo-elicitation study asked 30 women between 3 and 10 weeks postpartum to take photographs that encompassed their experience as a new mother during the pandemic. Two trained interviewers elicited elements of this experience using the photos as an anchor during virtual, hour-long interviews. Interview transcripts were analyzed using directed content analysis, including open coding to identify key ideas, codebook development, and codebook refinement. Half of transcripts were team coded to ensure coding accuracy. After coding, the study team organized codes to inform the development of an explanatory model. RESULTS: Interviews identified important stressors new mothers experienced that were worsened during the pandemic, namely fear, child care, older children, loss, isolation, and employment. Interviews also highlighted key support structures (self-care, interpersonal, and structural supports) that were at times helpful in alleviating stressors and at others were inadequate to counter stress and even enhanced stress. CONCLUSION: For postpartum individuals overall, the pandemic resulted in increased strain during an already stressful time. These findings demonstrate inadequacy of support systems for postpartum women and may highlight action items for stakeholders to improve postpartum care during the pandemic and in the future.